Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels. Cases, including severe infections, can still occur and it therefore remains essential to continue testing patients presenting with severe acute respiratory symptoms in order to guide treatment and inform epidemiological assessments.
Campylobacteriosis is the most frequently reported food- and waterborne disease in the EU/EEA. In 2018, 30 EU/EEA countries reported 250 384 confirmed cases of campylobacteriosis.
For 2020, 29 EU/EEA countries reported 123 062 confirmed cases of campylobacteriosis. This represents a reduction of 26.0% compared with 2019 (UK cases excluded).
The food-borne infections listeriosis and shigatoxigenic Escherichia coli are increasing in the EU/EEA and were in 2022 at levels higher than before the COVID-19 pandemic.
For 2022, 29 European Union/European Economic Area (EU/EEA) countries reported 8 565 confirmed cases of Shiga toxin-producing Escherichia coli (STEC) infection.
In 2022, the first and second most reported zoonoses in humans were campylobacteriosis and salmonellosis, respectively. The number of cases of campylobacteriosis and salmonellosis remained stable in comparison with 2021.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5-11 June 2023 and includes updates on Middle East respiratory syndrome coronavirus (MERS-CoV), COVID-19, Mpox, Marburg virus disease and West Nile virus.